Difference between revisions of "Uterine tumours"
Jump to navigation
Jump to search
(→Smooth muscle tumour of uncertain malignant potential (STUMP): tweak wording, subdivide) |
|||
(135 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
This article deals with '''uterine tumours''', | This article deals with '''[[uterus|uterine]] tumours''', with the exception of the tumours that arise from the [[endometrium]]. | ||
Uterine tumours are like water in the sea - very very common. Many hysterectomies are done for them. The most common are leiomyomata ([[AKA]] fibroids). | |||
Pre-malignant [[endometrium]] and endometrial tumours are dealt with in the articles, ''[[endometrial hyperplasia]]'' and ''[[endometrial carcinoma]]''. | |||
=Common benign= | |||
==Uterine leiomyoma== | |||
* | *Often called ''fibroids''. | ||
{{Main|Uterine leiomyoma}} | |||
=== | =Uncommon benign= | ||
==Uterine adenofibroma== | |||
* | *[[AKA]] ''[[adenofibroma]] of the uterus''. | ||
===General=== | ===General=== | ||
* | *Uncommmon. | ||
</ref> | *Benign looking lesions can reoccur.<ref name=pmid2351327>{{Cite journal | last1 = Seltzer | first1 = VL. | last2 = Levine | first2 = A. | last3 = Spiegel | first3 = G. | last4 = Rosenfeld | first4 = D. | last5 = Coffey | first5 = EL. | title = Adenofibroma of the uterus: multiple recurrences following wide local excision. | journal = Gynecol Oncol | volume = 37 | issue = 3 | pages = 427-31 | month = Jun | year = 1990 | doi = | PMID = 2351327 }}</ref> | ||
* | **It has been proposed that these lesions are in fact well-differentiated ''adenosarcomas''.<ref name=pmid18941402>{{Cite journal | last1 = Gallardo | first1 = A. | last2 = Prat | first2 = J. | title = Mullerian adenosarcoma: a clinicopathologic and immunohistochemical study of 55 cases challenging the existence of adenofibroma. | journal = Am J Surg Pathol | volume = 33 | issue = 2 | pages = 278-88 | month = Feb | year = 2009 | doi = 10.1097/PAS.0b013e318181a80d | PMID = 18941402 }}</ref> | ||
===Microscopic=== | |||
* | Features: | ||
*Moderately demarcated lesion with: | |||
**Pale stroma and epithelioid/spindle cells. | |||
**Simple cuboidal (or columnar) epithelium with eosinophilic cytoplasm. | |||
*Low mitotic rate. | |||
*Nuclear atypia minimal. | |||
Note: | |||
*Appearance similar to ''[[fibroadenoma]]''. | |||
* | |||
DDx: | DDx: | ||
* | *Adenosarcoma. | ||
Images: | |||
*[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496288/figure/F2/ Adenofibroma (nlm.nih.gov)].<ref>{{cite journal |authors=Chawla L, Vatsa R, Roy KK, Kumar S |title=Uterine Adenofibroma: An Unsual Cause of Nonpuerperal Uterine Inversion in Postmenopausal Female |journal=J Midlife Health |volume=8 |issue=2 |pages=95–97 |date=2017 |pmid=28706412 |pmc=5496288 |doi=10.4103/jmh.JMH_27_17 |url=}}</ref> | |||
== | ==Adenomatoid tumour== | ||
:Should '''not''' be confused with the [[bone tumour]] ''[[adamantinoma]]''. | |||
{{Main|Adenomatoid tumour}} | |||
== | =Uncertain malignant potential= | ||
==Smooth muscle tumour of uncertain malignant potential== | |||
*Abbreviated ''STUMP''. | |||
{{Main|Smooth muscle tumour of uncertain malignant potential}} | |||
=Malignant= | |||
* | ==Uterine carcinosarcoma== | ||
* [[AKA]] ''malignant mixed muellerian tumour'', abbreviated ''MMMT''. | |||
{{Main|Uterine carcinosarcoma}} | |||
==Adenosarcoma of the uterus== | |||
* | *[[AKA]] ''uterine adenosarcoma''. | ||
{{Main|Adenosarcoma of the uterus}} | |||
== | ==Uterine leiomyosarcoma== | ||
{{Main|Leiomyosarcoma}} | |||
===General=== | ===General=== | ||
*Poor prognosis. | *Poor prognosis. | ||
Line 98: | Line 61: | ||
===Gross=== | ===Gross=== | ||
Features: | |||
*"Fleshy" appearance. | *"Fleshy" appearance. | ||
*Necrosis. | *Necrosis. | ||
Line 104: | Line 68: | ||
===Microscopic=== | ===Microscopic=== | ||
Features: | |||
# | *Smooth muscle differentiation - '''essential'''. | ||
#*Should be patchy/multifocal. | **Fascicular architecture. | ||
#*Zonal necrosis is suggestive of vascular cause. | ***Whorled look at low power. | ||
#Mitoses | ***Groups of spindle cells cut peripendicular to their long axis adjacent to groups of spindle cells cut in the plane of their long axis. | ||
#*10 mitoses/HPF. | **May rely on [[IHC]] - if poorly differentiated. | ||
#*5 mitoses/HPF - if epithelioid. | *Malignant histomorphologic features - two of three required - '''key features''':<ref name=pmid21865091>{{Cite journal | last1 = Ip | first1 = PP. | last2 = Cheung | first2 = AN. | title = Pathology of uterine leiomyosarcomas and smooth muscle tumours of uncertain malignant potential. | journal = Best Pract Res Clin Obstet Gynaecol | volume = 25 | issue = 6 | pages = 691-704 | month = Dec | year = 2011 | doi = 10.1016/j.bpobgyn.2011.07.003 | PMID = 21865091 }}</ref> | ||
#*2 mitoses/HPF - if myxoid. | *#[[Nuclear pleomorphism]]. | ||
*#Coagulative tumour cell [[necrosis]] | |||
*#*Should be patchy/multifocal. | |||
*#*Zonal necrosis is suggestive of vascular cause and may be a degenerative change. | |||
*#**Zonal necrosis may be seen in (benign) leiomyomas. | |||
*#Mitoses. | |||
*#*10 mitoses/10 HPF. | |||
*#*5 mitoses/10 HPF - if epithelioid. | |||
*#*2 mitoses/10 HPF - if [[myxoid]]. | |||
Note: | |||
*The mitotic rate seems to be a relatively weak predictor; a modest rate may be malignant and a high rate benign.<ref name=pmid9388868>{{Cite journal | last1 = Guo | first1 = L. | last2 = Liu | first2 = T. | last3 = Huang | first3 = H. | title = [Reappraisal of the pathological criteria for uterine leiomyosarcoma]. | journal = Zhonghua Bing Li Xue Za Zhi | volume = 25 | issue = 5 | pages = 266-9 | month = Oct | year = 1996 | doi = | PMID = 9388868 }}</ref> | |||
DDx: | |||
*[[Endometrial stromal sarcoma]]. | |||
*[[Uterine carcinosarcoma]]. | |||
*[[Undifferentiated endometrial sarcoma]]. | |||
*[[Smooth muscle tumour of uncertain malignant potential]]. | |||
*[[Uterine leiomyoma]]. | |||
===IHC=== | ===IHC=== | ||
Line 119: | Line 101: | ||
**Caldesmon. | **Caldesmon. | ||
**Smooth muscle myosin. | **Smooth muscle myosin. | ||
*p16 +ve.<ref name=pmid18156978>{{Cite journal | last1 = Gannon | first1 = BR. | last2 = Manduch | first2 = M. | last3 = Childs | first3 = TJ. | title = Differential Immunoreactivity of p16 in leiomyosarcomas and leiomyoma variants. | journal = Int J Gynecol Pathol | volume = 27 | issue = 1 | pages = 68-73 | month = Jan | year = 2008 | doi = 10.1097/pgp.0b013e3180ca954f | PMID = 18156978 }}</ref> | |||
**Useful for differentiation from leiomyoma. | |||
= | =Endometrial stromal tumours= | ||
This grouping includes the gamut from benign to malignant. | |||
==Overview== | |||
WHO classification:<ref name=Ref_WMSP426>{{Ref WMSP|426}}</ref> | WHO classification:<ref name=Ref_WMSP426>{{Ref WMSP|426}}</ref> | ||
*Endometrial stromal nodule - not a tumour. | *Endometrial stromal nodule - not a tumour. | ||
*Endometrial stromal sarcoma (ESS), low grade. | *Endometrial stromal sarcoma (ESS), low grade. | ||
*Undifferentiated endometrial sarcoma | *Undifferentiated endometrial sarcoma (UES). | ||
Notes: | Notes: | ||
*Some believe in a "high grade ESS"... some don't.<ref name=pmid15491769>{{cite journal |author=Amant F, Vergote I, Moerman P |title=The classification of a uterine sarcoma as 'high-grade endometrial stromal sarcoma' should be abandoned |journal=Gynecol. Oncol. |volume=95 |issue=2 |pages=412–3; author reply 413 |year=2004 |month=November |pmid=15491769 |doi=10.1016/j.ygyno.2004.07.021 |url=http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6WG6-4DF46J8-3&_user=1166899&_coverDate=11%2F01%2F2004&_rdoc=1&_fmt=high&_orig=search&_sort=d&_docanchor=&view=c&_searchStrId=1204975755&_rerunOrigin=google&_acct=C000051839&_version=1&_urlVersion=0&_userid=1166899&md5=d6ec1eee2941460a085d1dac6615b5a5}}</ref> | *Some believe in a "high grade ESS"... some don't.<ref name=pmid15491769>{{cite journal |author=Amant F, Vergote I, Moerman P |title=The classification of a uterine sarcoma as 'high-grade endometrial stromal sarcoma' should be abandoned |journal=Gynecol. Oncol. |volume=95 |issue=2 |pages=412–3; author reply 413 |year=2004 |month=November |pmid=15491769 |doi=10.1016/j.ygyno.2004.07.021 |url=http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6WG6-4DF46J8-3&_user=1166899&_coverDate=11%2F01%2F2004&_rdoc=1&_fmt=high&_orig=search&_sort=d&_docanchor=&view=c&_searchStrId=1204975755&_rerunOrigin=google&_acct=C000051839&_version=1&_urlVersion=0&_userid=1166899&md5=d6ec1eee2941460a085d1dac6615b5a5}}</ref> | ||
== | ==Endometrial stromal nodule== | ||
*Abbreviated ''ESN''. | |||
===General=== | |||
*Benign. | |||
===Microscopic=== | ===Microscopic=== | ||
Features: | Features: | ||
* | *Well-circumscribed - '''key feature'''. | ||
** | **The interface of the lesion may not have more than three finger-like irregularities/projections into the surround myometrium that are >= 3 mm.<ref name=pmid17347285>{{Cite journal | last1 = Baker | first1 = P. | last2 = Oliva | first2 = E. | title = Endometrial stromal tumours of the uterus: a practical approach using conventional morphology and ancillary techniques. | journal = J Clin Pathol | volume = 60 | issue = 3 | pages = 235-43 | month = Mar | year = 2007 | doi = 10.1136/jcp.2005.031203 | PMID = 17347285 | url = http://jcp.bmj.com/content/60/3/235.full }}</ref> | ||
** | ***If it does... it is an [[ESS]]. | ||
* | *No [[vascular invasion]]. | ||
DDx: | |||
* | *[[Endometrial stromal sarcoma]] (ESS), [[UES]] - myometrial invasion or [[vascular invasion]]. | ||
Images: | |||
*[http://commons.wikimedia.org/wiki/File: | *[http://commons.wikimedia.org/wiki/File:EndometrialStromalNodule.JPG ESN (WC)]. | ||
==Endometrial stromal sarcoma== | |||
* | *Abbreviated ESS. | ||
*Previously known as ''low-grade endometrial stromal sarcoma''. | |||
{{Main|Endometrial stromal sarcoma}} | |||
==Undifferentiated endometrial sarcoma== | ==Undifferentiated endometrial sarcoma== | ||
*Abbreviated as ''UES''. | |||
*Previously known as ''high-grade endometrial stromal sarcoma''.<ref name=pmid24146786>{{Cite journal | last1 = Feng | first1 = W. | last2 = Malpica | first2 = A. | last3 = Skaland | first3 = I. | last4 = Gudlaugsson | first4 = E. | last5 = Robboy | first5 = SJ. | last6 = Dalen | first6 = I. | last7 = Hua | first7 = K. | last8 = Zhou | first8 = X. | last9 = Baak | first9 = JP. | title = Can proliferation biomarkers reliably predict recurrence in world health organization 2003 defined endometrial stromal sarcoma, low grade? | journal = PLoS One | volume = 8 | issue = 10 | pages = e75899 | month = | year = 2013 | doi = 10.1371/journal.pone.0075899 | PMID = 24146786 }}</ref> | |||
===General=== | |||
*Malignant. | |||
*Rare. | |||
*This can be thought of as ''[[pleomorphic undifferentiated sarcoma]]'' in the [[uterus]]. | |||
===Microscopic=== | |||
Features: | Features: | ||
#Marked nuclear atypia. | #Marked nuclear atypia. | ||
Line 179: | Line 161: | ||
DDx: | DDx: | ||
*[[Leiomyosarcoma]]. | *[[Leiomyosarcoma]]. | ||
*Carcinosarcoma. | *[[Uterine carcinosarcoma|Carcinosarcoma]]. | ||
*[[Rhabdomyosarcoma]]. | *[[Rhabdomyosarcoma]]. | ||
*[[Melanoma]]. | *[[Melanoma]]. | ||
== | ===IHC=== | ||
=== | Features:<ref name=pmid21464730>{{Cite journal | last1 = Abeler | first1 = VM. | last2 = Nenodovic | first2 = M. | title = Diagnostic immunohistochemistry in uterine sarcomas: a study of 397 cases. | journal = Int J Gynecol Pathol | volume = 30 | issue = 3 | pages = 236-43 | month = May | year = 2011 | doi = 10.1097/PGP.0b013e318200caff | PMID = 21464730 }}</ref> | ||
* | *SMA ~50% +ve. | ||
** | |||
Typically negative:<ref name=pmid21464730/> | |||
*Smooth muscle markers: desmin, h-caldesmon. | |||
*Skeletal muscle markers: Myf4, actin. | |||
*Melanoma: S100, HMB-45. | |||
*GIST: CD117. | |||
=Weird stuff= | |||
==Trophoblastic tumours== | |||
*[[Choriocarcinoma]]. | |||
*[[Epithelioid trophoblastic tumour]]. | |||
*[[Placental site trophoblastic tumour]]. | |||
==Uterine tumour resembling an ovarian sex cord stromal tumour== | |||
*Abbreviated ''UTROSCT''. | |||
{{Main|Uterine tumour resembling an ovarian sex cord stromal tumour}} | |||
==Atypical polypoid adenomyoma of the uterus== | |||
*Abbreviated ''APA''. | |||
*[[AKA]] ''atypical polypoid adenomyoma''. | |||
{{Main|Atypical polypoid adenomyoma of the uterus}} | |||
=See also= | |||
*[[Gynecologic pathology]]. | *[[Gynecologic pathology]]. | ||
*[[Endometrial carcinoma]]. | *[[Endometrial carcinoma]]. | ||
*[[Endometrial hyperplasia]]. | *[[Endometrial hyperplasia]]. | ||
*[[Endometrial polyp]]. | |||
=References= | |||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Gynecologic pathology]] | [[Category:Gynecologic pathology]] |
Latest revision as of 15:26, 10 January 2022
This article deals with uterine tumours, with the exception of the tumours that arise from the endometrium.
Uterine tumours are like water in the sea - very very common. Many hysterectomies are done for them. The most common are leiomyomata (AKA fibroids).
Pre-malignant endometrium and endometrial tumours are dealt with in the articles, endometrial hyperplasia and endometrial carcinoma.
Common benign
Uterine leiomyoma
- Often called fibroids.
Main article: Uterine leiomyoma
Uncommon benign
Uterine adenofibroma
- AKA adenofibroma of the uterus.
General
- Uncommmon.
- Benign looking lesions can reoccur.[1]
- It has been proposed that these lesions are in fact well-differentiated adenosarcomas.[2]
Microscopic
Features:
- Moderately demarcated lesion with:
- Pale stroma and epithelioid/spindle cells.
- Simple cuboidal (or columnar) epithelium with eosinophilic cytoplasm.
- Low mitotic rate.
- Nuclear atypia minimal.
Note:
- Appearance similar to fibroadenoma.
DDx:
- Adenosarcoma.
Images:
Adenomatoid tumour
- Should not be confused with the bone tumour adamantinoma.
Main article: Adenomatoid tumour
Uncertain malignant potential
Smooth muscle tumour of uncertain malignant potential
- Abbreviated STUMP.
Main article: Smooth muscle tumour of uncertain malignant potential
Malignant
Uterine carcinosarcoma
- AKA malignant mixed muellerian tumour, abbreviated MMMT.
Main article: Uterine carcinosarcoma
Adenosarcoma of the uterus
- AKA uterine adenosarcoma.
Main article: Adenosarcoma of the uterus
Uterine leiomyosarcoma
Main article: Leiomyosarcoma
General
- Poor prognosis.
- Do not (generally) arise from leiomyomas.
- Often singular, i.e. one tumour; unlike leiomyomas (which are often multiple).
Gross
Features:
- "Fleshy" appearance.
- Necrosis.
- Large size.
- Often singular, i.e. one lesion; leiomyomata are often multiple.
Microscopic
Features:
- Smooth muscle differentiation - essential.
- Fascicular architecture.
- Whorled look at low power.
- Groups of spindle cells cut peripendicular to their long axis adjacent to groups of spindle cells cut in the plane of their long axis.
- May rely on IHC - if poorly differentiated.
- Fascicular architecture.
- Malignant histomorphologic features - two of three required - key features:[4]
- Nuclear pleomorphism.
- Coagulative tumour cell necrosis
- Should be patchy/multifocal.
- Zonal necrosis is suggestive of vascular cause and may be a degenerative change.
- Zonal necrosis may be seen in (benign) leiomyomas.
- Mitoses.
- 10 mitoses/10 HPF.
- 5 mitoses/10 HPF - if epithelioid.
- 2 mitoses/10 HPF - if myxoid.
Note:
- The mitotic rate seems to be a relatively weak predictor; a modest rate may be malignant and a high rate benign.[5]
DDx:
- Endometrial stromal sarcoma.
- Uterine carcinosarcoma.
- Undifferentiated endometrial sarcoma.
- Smooth muscle tumour of uncertain malignant potential.
- Uterine leiomyoma.
IHC
- CD10 -ve.
- Positive for SMC markers.
- Desmin - present in all three types of muscle.
- Caldesmon.
- Smooth muscle myosin.
- p16 +ve.[6]
- Useful for differentiation from leiomyoma.
Endometrial stromal tumours
This grouping includes the gamut from benign to malignant.
Overview
WHO classification:[7]
- Endometrial stromal nodule - not a tumour.
- Endometrial stromal sarcoma (ESS), low grade.
- Undifferentiated endometrial sarcoma (UES).
Notes:
- Some believe in a "high grade ESS"... some don't.[8]
Endometrial stromal nodule
- Abbreviated ESN.
General
- Benign.
Microscopic
Features:
- Well-circumscribed - key feature.
- No vascular invasion.
DDx:
- Endometrial stromal sarcoma (ESS), UES - myometrial invasion or vascular invasion.
Images:
Endometrial stromal sarcoma
- Abbreviated ESS.
- Previously known as low-grade endometrial stromal sarcoma.
Main article: Endometrial stromal sarcoma
Undifferentiated endometrial sarcoma
- Abbreviated as UES.
- Previously known as high-grade endometrial stromal sarcoma.[10]
General
- Malignant.
- Rare.
- This can be thought of as pleomorphic undifferentiated sarcoma in the uterus.
Microscopic
Features:
- Marked nuclear atypia.
- Mitoses+++.
- Poorly differentiated - key feature
- Looks nothing like low grade endometrial stromal sarcoma.
- Negative for smooth muscle markers (to exclude leiomyosarcoma).
Notes:
- Need IHC to diagnose.
DDx:
IHC
Features:[11]
- SMA ~50% +ve.
Typically negative:[11]
- Smooth muscle markers: desmin, h-caldesmon.
- Skeletal muscle markers: Myf4, actin.
- Melanoma: S100, HMB-45.
- GIST: CD117.
Weird stuff
Trophoblastic tumours
Uterine tumour resembling an ovarian sex cord stromal tumour
- Abbreviated UTROSCT.
Atypical polypoid adenomyoma of the uterus
- Abbreviated APA.
- AKA atypical polypoid adenomyoma.
Main article: Atypical polypoid adenomyoma of the uterus
See also
References
- ↑ Seltzer, VL.; Levine, A.; Spiegel, G.; Rosenfeld, D.; Coffey, EL. (Jun 1990). "Adenofibroma of the uterus: multiple recurrences following wide local excision.". Gynecol Oncol 37 (3): 427-31. PMID 2351327.
- ↑ Gallardo, A.; Prat, J. (Feb 2009). "Mullerian adenosarcoma: a clinicopathologic and immunohistochemical study of 55 cases challenging the existence of adenofibroma.". Am J Surg Pathol 33 (2): 278-88. doi:10.1097/PAS.0b013e318181a80d. PMID 18941402.
- ↑ Chawla L, Vatsa R, Roy KK, Kumar S (2017). "Uterine Adenofibroma: An Unsual Cause of Nonpuerperal Uterine Inversion in Postmenopausal Female". J Midlife Health 8 (2): 95–97. doi:10.4103/jmh.JMH_27_17. PMC 5496288. PMID 28706412. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496288/.
- ↑ Ip, PP.; Cheung, AN. (Dec 2011). "Pathology of uterine leiomyosarcomas and smooth muscle tumours of uncertain malignant potential.". Best Pract Res Clin Obstet Gynaecol 25 (6): 691-704. doi:10.1016/j.bpobgyn.2011.07.003. PMID 21865091.
- ↑ Guo, L.; Liu, T.; Huang, H. (Oct 1996). "[Reappraisal of the pathological criteria for uterine leiomyosarcoma].". Zhonghua Bing Li Xue Za Zhi 25 (5): 266-9. PMID 9388868.
- ↑ Gannon, BR.; Manduch, M.; Childs, TJ. (Jan 2008). "Differential Immunoreactivity of p16 in leiomyosarcomas and leiomyoma variants.". Int J Gynecol Pathol 27 (1): 68-73. doi:10.1097/pgp.0b013e3180ca954f. PMID 18156978.
- ↑ Humphrey, Peter A; Dehner, Louis P; Pfeifer, John D (2008). The Washington Manual of Surgical Pathology (1st ed.). Lippincott Williams & Wilkins. pp. 426. ISBN 978-0781765275.
- ↑ Amant F, Vergote I, Moerman P (November 2004). "The classification of a uterine sarcoma as 'high-grade endometrial stromal sarcoma' should be abandoned". Gynecol. Oncol. 95 (2): 412–3; author reply 413. doi:10.1016/j.ygyno.2004.07.021. PMID 15491769. http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6WG6-4DF46J8-3&_user=1166899&_coverDate=11%2F01%2F2004&_rdoc=1&_fmt=high&_orig=search&_sort=d&_docanchor=&view=c&_searchStrId=1204975755&_rerunOrigin=google&_acct=C000051839&_version=1&_urlVersion=0&_userid=1166899&md5=d6ec1eee2941460a085d1dac6615b5a5.
- ↑ Baker, P.; Oliva, E. (Mar 2007). "Endometrial stromal tumours of the uterus: a practical approach using conventional morphology and ancillary techniques.". J Clin Pathol 60 (3): 235-43. doi:10.1136/jcp.2005.031203. PMID 17347285. http://jcp.bmj.com/content/60/3/235.full.
- ↑ Feng, W.; Malpica, A.; Skaland, I.; Gudlaugsson, E.; Robboy, SJ.; Dalen, I.; Hua, K.; Zhou, X. et al. (2013). "Can proliferation biomarkers reliably predict recurrence in world health organization 2003 defined endometrial stromal sarcoma, low grade?". PLoS One 8 (10): e75899. doi:10.1371/journal.pone.0075899. PMID 24146786.
- ↑ 11.0 11.1 Abeler, VM.; Nenodovic, M. (May 2011). "Diagnostic immunohistochemistry in uterine sarcomas: a study of 397 cases.". Int J Gynecol Pathol 30 (3): 236-43. doi:10.1097/PGP.0b013e318200caff. PMID 21464730.